Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Rheumatol

Retrieve available abstracts of 142 articles:
HTML format



Single Articles


    November 2022
  1. GERMONPRE S, Mulier S, Falzon L, Boonen A, et al
    Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Exp Rheumatol. 2022 Nov 24. doi: 10.55563.
    PubMed     Abstract available


  2. DE SOUZA FFL, Schneider AH, Machado CC, de Almeida SCL, et al
    Synovial fluid survivin and NETs as independent biomarkers in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Nov 24. doi: 10.55563.
    PubMed     Abstract available


  3. WAJDA A, Stypinska B, Czarnecka M, Hasan D, et al
    Are SMAD2/4/7 genetic variants associated with rheumatoid arthritis susceptibility and severity?
    Clin Exp Rheumatol. 2022 Nov 13. pii: 18825.
    PubMed     Abstract available


  4. NOVELLA-NAVARRO M, Ruiz-Esquide V, Torres-Ortiz G, Chacur CA, et al
    A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification.
    Clin Exp Rheumatol. 2022 Nov 13. pii: 18765.
    PubMed     Abstract available


  5. VITTECOQ O, Kozyreff-Meurice M, Houivet E, Leon N, et al
    Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study.
    Clin Exp Rheumatol. 2022 Nov 12. pii: 18669.
    PubMed     Abstract available


  6. BEN-CHETRIT E, Ben-Chetrit E
    Reply to comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2022;40:2201.
    PubMed    


  7. ANDREICA I, Jast R, Rezniczek GA, Kiefer D, et al
    Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
    Clin Exp Rheumatol. 2022;40:2044-2051.
    PubMed     Abstract available


    October 2022
  8. ZHANG X, Wang H, Song X, Song Y, et al
    Compound 78c exerts a therapeutic effect on collagen-induced arthritis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 29. pii: 18748.
    PubMed     Abstract available


  9. TANAKA Y, Takahashi T, Van Hoogstraten H, Praestgaard A, et al
    Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab.
    Clin Exp Rheumatol. 2022 Oct 28. pii: 18235.
    PubMed     Abstract available


  10. CHANG CK, Chang KH, Cheng WC, Chen PK, et al
    Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 4. pii: 18824.
    PubMed     Abstract available


  11. JEONG E, Jung JY, Lee MJ, Kim HA, et al
    A link between CD8+CD27-CD28- T cells expressing chemerin chemokine-like receptor 1 and rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Oct 4. pii: 18772.
    PubMed     Abstract available


    September 2022
  12. DING JT, Hong FF, Yang SL
    Roles of autophagy in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Sep 22. pii: 18442.
    PubMed     Abstract available


  13. YAVROPOULOU MP, Filippa MG, Panopoulos S, Spanos E, et al
    Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
    Clin Exp Rheumatol. 2022;40:1789-1792.
    PubMed     Abstract available


  14. YANG H, Luo Y, Lai X
    Il-34 regulates MAPKs, PI3K/Akt, JAK and NF-kappaB pathways and induces the expression of inflammatory factors in RA-FLS.
    Clin Exp Rheumatol. 2022;40:1779-1788.
    PubMed     Abstract available


  15. WESTON S, Macdonald JL, Williams LM, Roussou E, et al
    The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Clin Exp Rheumatol. 2022;40:1620-1628.
    PubMed     Abstract available


    August 2022
  16. LEE JY, Kim SH, Lee SH, Kim HR, et al
    Effect of Janus kinase inhibitors on T cell responses to herpes zoster in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Aug 31. pii: 18678.
    PubMed     Abstract available


  17. JUNG JY, Lee E, Kim JW, Suh CH, et al
    Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry.
    Clin Exp Rheumatol. 2022 Aug 31. pii: 18570.
    PubMed     Abstract available


  18. DUARTE C, Santos E, Barreira SC, Avila-Ribeiro P, et al
    Can numerical rating scales of disease impact be used as targets for patient-centred management in rheumatoid arthritis?
    Clin Exp Rheumatol. 2022 Aug 5. pii: 18562.
    PubMed     Abstract available


  19. KOUKI I, Sacco I, Eymard F, Fautrel B, et al
    An adult-onset Still's disease during infection with Chlamydia trachomatis.
    Clin Exp Rheumatol. 2022 Aug 1. pii: 18800.
    PubMed    


    July 2022
  20. DROSOS AA, Pelechas E, Venetsanopoulou AI, Voulgari PV, et al
    Comment on: Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2022 Jul 26. pii: 18811.
    PubMed    


  21. GUELLEC D, Carvajal-Alegria G, Daien C, Gossec L, et al
    Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort.
    Clin Exp Rheumatol. 2022 Jul 21. pii: 18514.
    PubMed     Abstract available


  22. GARAFFONI C, Adinolfi A, Bortoluzzi A, Filippou G, et al
    Novel insights into the management of rheumatoid arthritis: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:1247-1257.
    PubMed     Abstract available


  23. PELLEGRINO G, Mancuso S, Colasanti T, Mieli S, et al
    Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study.
    Clin Exp Rheumatol. 2022;40:1417-1419.
    PubMed     Abstract available


  24. GALLOWAY J, Raine T, Rivett L, Roberts J, et al
    Herpes zoster and Janus kinase inhibition in rheumatology and gastroenterology patients: managing risk and vaccination.
    Clin Exp Rheumatol. 2022;40:1432-1441.
    PubMed     Abstract available


  25. RAVAEI A, Rubini M
    Rescuing effect of folates on methotrexate cytotoxicity in human trophoblast cells.
    Clin Exp Rheumatol. 2022;40:1403-1410.
    PubMed     Abstract available


    June 2022
  26. SAKELLARIOU G, Carrara G, Zanetti A, Scire CA, et al
    Do we need Early Arthritis Clinics to counteract the excess of mortality in rheumatoid arthritis?
    Clin Exp Rheumatol. 2022 Jun 28. pii: 18227.
    PubMed    


  27. WEMAN L, Vehmas J, Immonen J, Hannonen P, et al
    Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011.
    Clin Exp Rheumatol. 2022 Jun 28. pii: 18494.
    PubMed     Abstract available


  28. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
    Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose.
    Clin Exp Rheumatol. 2022 Jun 13. pii: 18477.
    PubMed     Abstract available


  29. GUL HL, Di Matteo A, Mankia K, Wu J, et al
    Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?
    Clin Exp Rheumatol. 2022 Jun 13. pii: 18334.
    PubMed     Abstract available


    May 2022
  30. LEE H, Chen SK, Gautam N, Vine SM, et al
    Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
    Clin Exp Rheumatol. 2022 May 10. pii: 18274.
    PubMed     Abstract available


  31. DI COLA I, Di Muzio C, Conforti A, Iacono D, et al
    Adult-onset Still's disease with elderly onset, results from a multicentre study.
    Clin Exp Rheumatol. 2022 May 4. pii: 18230.
    PubMed     Abstract available


  32. CECCARELLI F, Spinelli FR, Garufi C, Mancuso S, et al
    The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort.
    Clin Exp Rheumatol. 2022;40:921-927.
    PubMed     Abstract available


  33. GAUD-LISTRAT V, Lopez-Medina C, Hudry C, Nguyen M, et al
    Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study.
    Clin Exp Rheumatol. 2022;40:928-935.
    PubMed     Abstract available


  34. BALDINI C, Arnaud L, Avcin T, Beretta L, et al
    Sjogren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.
    Clin Exp Rheumatol. 2022;40 Suppl 134:103-112.
    PubMed     Abstract available


  35. MUCKE J, Cornet A, Witte T, Schneider M, et al
    Association of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review.
    Clin Exp Rheumatol. 2022;40 Suppl 134:40-45.
    PubMed     Abstract available


  36. PETITDEMANGE A, Sztejkowski C, Damian L, Martin T, et al
    Treatment of relapsing polychondritis: a systematic review.
    Clin Exp Rheumatol. 2022;40 Suppl 134:81-85.
    PubMed     Abstract available


    April 2022
  37. LARSSON C, Andersson KME, Nadali M, Silfversward ST, et al
    MicroRNA and interleukin 6 interplay in the adipose tissue of rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Apr 29. pii: 18013.
    PubMed     Abstract available


  38. MARTIN-GONZALEZ C, Martin-Folgueras T, Quevedo-Abeledo JC, de Armas-Rillo L, et al
    Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.
    Clin Exp Rheumatol. 2022 Apr 6. pii: 18203.
    PubMed     Abstract available


    March 2022
  39. KEYSTONE E, Movahedi M, Cesta A, Bombardier C, et al
    Differential influence of Clinical Disease Activity Index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative.
    Clin Exp Rheumatol. 2022 Mar 30. pii: 17725.
    PubMed     Abstract available


  40. LIN T, Xu S, Wang Y, Nian X, et al
    Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease.
    Clin Exp Rheumatol. 2022 Mar 23. pii: 18186.
    PubMed     Abstract available


  41. CAMPOCHIARO C, Farina N, Tomelleri A, De Luca G, et al
    Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease.
    Clin Exp Rheumatol. 2022 Mar 18. pii: 17994.
    PubMed    


  42. KLEMM P, Hoffmann J, Asendorf T, Aykara I, et al
    Whole-body cryotherapy for the treatment of rheumatoid arthritis: a monocentric, single-blinded, randomised controlled trial.
    Clin Exp Rheumatol. 2022 Mar 1. pii: 17706.
    PubMed     Abstract available


  43. PETRELLI F, Mariani FM, Alunno A, Puxeddu I, et al
    Pathogenesis of rheumatoid arthritis: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:475-482.
    PubMed     Abstract available


  44. HUANG T, Li Y, Luo Y, Zhou Y, et al
    Research progress on the pathogenesis and quality of life of patients with primary Sjogren's syndrome complicated by depression.
    Clin Exp Rheumatol. 2022;40:647-654.
    PubMed     Abstract available


    February 2022
  45. VERHOEVEN MMA, Westgeest AAA, Tekstra J, van Laar JM, et al
    Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts.
    Clin Exp Rheumatol. 2022 Feb 17. pii: 17657.
    PubMed     Abstract available


  46. KANG JH, Choi SE, Xu H, Park DJ, et al
    Non-adherence to methotrexate was associated with high disease activity and poor health-related outcomes during a 4-year follow-up of rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Feb 17. pii: 17574.
    PubMed     Abstract available


  47. NODA K, Saitou M, Matsushita T, Ukichi T, et al
    How do central sensitisation features affect symptoms among patients with rheumatoid arthritis? Analysis of pain descriptors and the effect of central sensitivity syndrome on patient and evaluator global assessments.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 17676.
    PubMed     Abstract available


  48. WU B, Peng R, Chen Y, Zhong J, et al
    Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 17730.
    PubMed     Abstract available


  49. MURRAY MT, Penney SP, Landman A, Elias J, et al
    User experience with a voice-enabled smartphone app to collect patient-reported outcomes in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 16841.
    PubMed     Abstract available


    January 2022
  50. HIROHATA S, Nagai T, Tomita T
    Enhanced expression of mRNA for transforming growth factor beta activated kinase 1 in CD34+ cells of the bone marrow in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Jan 27. pii: 17941.
    PubMed     Abstract available


  51. MASNERI S, Piantoni S, Galoppini G, Regola F, et al
    CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept.
    Clin Exp Rheumatol. 2022 Jan 27. pii: 17712.
    PubMed     Abstract available


  52. KALYONCU U, Bilgin E, Erden A, Satis H, et al
    Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
    Clin Exp Rheumatol. 2022 Jan 25. pii: 17973.
    PubMed     Abstract available


  53. TAKASHIMA Y, Hayashi S, Maeda T, Fukuda K, et al
    Histopathological changes of synovial tissue in rheumatoid arthritis patients treated with TNF-alpha inhibitors or IL-6 inhibitors.
    Clin Exp Rheumatol. 2022 Jan 25. pii: 17785.
    PubMed     Abstract available


  54. SMITH ID, Lu N, Wei J, Zhang Y, et al
    Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Jan 25. pii: 17761.
    PubMed     Abstract available


  55. FORNARO M, Benaglio F, Montecucco C, Raffeiner B, et al
    Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of t
    Clin Exp Rheumatol. 2022 Jan 12. pii: 17698.
    PubMed     Abstract available


  56. NOVELLA-NAVARRO M, Genre F, Hernandez-Breijo B, Remuzgo-Martinez S, et al
    Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines.
    Clin Exp Rheumatol. 2022 Jan 12. pii: 17782.
    PubMed     Abstract available


  57. MYACHIKOVA V, Moiseeva O, Konradi A, Lapin SV, et al
    A retrospective analysis of colchicine in combination with NSAIDs therapy in patients with systemic form of adult-onset Still's disease with serositis.
    Clin Exp Rheumatol. 2022 Jan 12. pii: 17765.
    PubMed     Abstract available


  58. ISSA SF, Lindegaard HM, Lorenzen T, Junker K, et al
    Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
    Clin Exp Rheumatol. 2022;40:198.
    PubMed    


    December 2021
  59. PODGORSKA D, Ciesla M, Majdan M, Podgorski R, et al
    The relationship of ADAMTSL2 and LRPAP1 gene methylation level with rheumatoid arthritis activity.
    Clin Exp Rheumatol. 2021 Dec 22. pii: 17757.
    PubMed     Abstract available


    November 2021
  60. MODARRESI CHAHARDEHI A, Masoumi SA, Bigdeloo M, Arsad H, et al
    The effect of exercise on patients with rheumatoid arthritis on the modulation of inflammation.
    Clin Exp Rheumatol. 2021 Nov 23. pii: 17457.
    PubMed     Abstract available


  61. SPECKER C, Aringer M, Burmester GR, Killy B, et al
    The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age.
    Clin Exp Rheumatol. 2021 Nov 22. pii: 17272.
    PubMed     Abstract available


  62. LAYEGH Z, Hooijberg F, Bastida C, Huitema ADR, et al
    Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17173.
    PubMed    


  63. SUGAWARA M, Fujieda Y, Noguchi A, Tanimura S, et al
    Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17548.
    PubMed     Abstract available


  64. ALDRIDGE J, Lundell AC, Andersson K, Mark L, et al
    Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17505.
    PubMed     Abstract available


  65. BEN-CHETRIT E, Ben-Chetrit E
    Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2021;39:1410-1412.
    PubMed     Abstract available


  66. CHOWDHURY F, Grigoriadou S, Bombardieri M
    Severity of COVID-19 infection in primary Sjogren's syndrome and the emerging evidence of COVID-19-induced xerostomia.
    Clin Exp Rheumatol. 2021;39 Suppl 133:215-222.
    PubMed     Abstract available


  67. RETAMOZO S, Acar-Denizli N, Horvath IF, Ng WF, et al
    Influence of the age at diagnosis in the disease expression of primary Sjogren syndrome. Analysis of 12,753 patients from the Sjogren Big Data Consortium.
    Clin Exp Rheumatol. 2021;39 Suppl 133:166-174.
    PubMed     Abstract available


  68. DUBOST JJ, Couderc M, Pereira B, Mariette X, et al
    Concomitant fibromyalgia in primary Sjogren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
    Clin Exp Rheumatol. 2021;39 Suppl 133:140-145.
    PubMed     Abstract available


  69. LOUREIRO-AMIGO J, Franco-Jarava C, Perurena-Prieto J, Palacio C, et al
    Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:131-139.
    PubMed     Abstract available


  70. CAFARO G, Bursi R, Chatzis LG, Fulvio G, et al
    One year in review 2021: Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:3-13.
    PubMed     Abstract available


  71. SISO-ALMIRALL A, Meijer JM, Brito-Zeron P, Conangla L, et al
    Practical guidelines for the early diagnosis of Sjogren's syndrome in primary healthcare.
    Clin Exp Rheumatol. 2021;39 Suppl 133:197-205.
    PubMed     Abstract available


  72. CARUBBI F, Alunno A, Mai F, Mercuri A, et al
    Adherence to the Mediterranean diet and the impact on clinical features in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:190-196.
    PubMed     Abstract available


  73. SEGHIERI C, Lupi E, Tzioufas AG, De Vita S, et al
    Patient-reported experience and health-related quality of life in patients with primary Sjogren's syndrome in Europe.
    Clin Exp Rheumatol. 2021;39 Suppl 133:123-130.
    PubMed     Abstract available


  74. BRITO-ZERON P, Acar-Denizli N, Romao VC, Armagan B, et al
    Post-COVID-19 syndrome in patients with primary Sjogren's syndrome after acute SARS-CoV-2 infection.
    Clin Exp Rheumatol. 2021;39 Suppl 133:57-65.
    PubMed     Abstract available


  75. KOH JH, Park Y, Lee J, Park SH, et al
    Hypergammaglobulinaemia predicts glandular and extra-glandular damage in primary Sjogren's syndrome: results from the KISS cohort study.
    Clin Exp Rheumatol. 2021;39 Suppl 133:114-122.
    PubMed     Abstract available


  76. LEGGER GE, Erdtsieck MB, de Wolff L, Stel AJ, et al
    Differences in presentation between paediatric- and adult-onset primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2021;39 Suppl 133:85-92.
    PubMed     Abstract available


  77. ZHANG X, Zhang S, Feng R, Yao H, et al
    Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:184-189.
    PubMed     Abstract available


  78. DE WOLFF L, Arends S, Pontarini E, Bombardieri M, et al
    Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:100-106.
    PubMed     Abstract available


  79. BEJARANO MV, Romanini F, Catalan Pellet A, Mamani MN, et al
    Work productivity and activity impairment in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:93-99.
    PubMed     Abstract available


  80. CHATZIS LG, Goules AV, Tzioufas AG
    Searching for the "X factor" in Sjogren's syndrome female predilection.
    Clin Exp Rheumatol. 2021;39 Suppl 133:206-214.
    PubMed     Abstract available


  81. LORENZON M, Tulipano Di Franco F, Zabotti A, Pegolo E, et al
    Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:175-183.
    PubMed     Abstract available


  82. FARENHORST CA, de Wolff L, Arends S, van Nimwegen JF, et al
    Clinical determinants of vaginal dryness in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:73-79.
    PubMed     Abstract available


  83. PRINGLE SA, Berkhof B, van Ginkel M, Liefers S, et al
    Parotid salivary sodium levels of Sjogren's syndrome patients suggest B-cell mediated epithelial sodium channel disruption.
    Clin Exp Rheumatol. 2021;39 Suppl 133:30-38.
    PubMed     Abstract available


  84. CHATZIS LG, Pezoulas V, Voulgari PV, Baldini C, et al
    Combined seronegativity in Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:80-84.
    PubMed     Abstract available


  85. GOZUKUCUK M, Turkyilmaz E, Kucuksahin O, Erten S, et al
    Effects of primary Sjogren's syndrome on female genitalia and sexual functions.
    Clin Exp Rheumatol. 2021;39 Suppl 133:66-72.
    PubMed     Abstract available


  86. PENG X, Lu Y, Wei J, Lin T, et al
    A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjogren's syndrome patients with dry eye disease.
    Clin Exp Rheumatol. 2021;39 Suppl 133:159-165.
    PubMed     Abstract available


  87. COLEBY R, Lucchesi D, Pontarini E, Pitzalis C, et al
    Stepwise changes in the murine salivary gland immune response during virally-induced ectopic lymphoid structure formation.
    Clin Exp Rheumatol. 2021;39 Suppl 133:39-48.
    PubMed     Abstract available


  88. HERNANDEZ-MOLINA G, Soto-Abraham V, Zamora-Legoff V, Furuzawa-Carballeda J, et al
    Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjogren's syndrome and systemic lupus erythematosus associated with Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:49-56.
    PubMed     Abstract available


  89. RAMOS-CASALS M, Sainz-de-la-Maza M, Muxi A
    COVID-19 vaccination unveiling subclinical Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:228-229.
    PubMed    


  90. XU T, Guo Y, Lu J, Shan J, et al
    Untargeted serum metabolomics and potential biomarkers for Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:23-29.
    PubMed     Abstract available


  91. SANDOVAL-FLORES MG, Chan-Campos I, Hernandez-Molina G
    Factors influencing the EULAR Sjogren's Syndrome Patient-Reported Index in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:153-158.
    PubMed     Abstract available


  92. KOMORI K, Komori M, Horino T, Nishiyama S, et al
    Factors associated with delayed diagnosis of Sjogren's syndrome among members of the Japanese Sjogren's Association for Patients.
    Clin Exp Rheumatol. 2021;39 Suppl 133:146-152.
    PubMed     Abstract available


  93. GUNDOGUS B, Yildiz T, Agca M, Erdagi A, et al
    Sjogren's syndrome and pulmonary alveolar proteinosis co-existence.
    Clin Exp Rheumatol. 2021;39 Suppl 133:230.
    PubMed    


  94. LANG J, Shi X, Ma Y, Zou L, et al
    Primary Sjogren's syndrome with minimal change disease: case series and literature review.
    Clin Exp Rheumatol. 2021;39 Suppl 133:226-227.
    PubMed    


  95. JAGER-WITTENAAR H, Vissink A, Kroese FGM, Bootsma H, et al
    Undernutrition and sarcopenic obesity: underrecognised conditions in patients with Sjogren's syndrome?
    Clin Exp Rheumatol. 2021;39 Suppl 133:20-22.
    PubMed    


  96. VIEIRA A, Grosjean A, Stone L, Oosterbaan M, et al
    Sjogren's: the European patients' community perspective.
    Clin Exp Rheumatol. 2021;39 Suppl 133:14-16.
    PubMed    


  97. GENET L, Jalladaud M, Seror R, Gosset M, et al
    Plasma cell gingivitis, an underestimated condition in patients with Sjogren's syndrome?
    Clin Exp Rheumatol. 2021;39 Suppl 133:225.
    PubMed    


  98. IZUKA S, Yamashita H, Takahashi Y, Kaneko H, et al
    Type II cryoglobulinaemic vasculitis with primary Sjogren's syndrome successfully treated with belimumab and hydroxychloroquine.
    Clin Exp Rheumatol. 2021;39 Suppl 133:223-224.
    PubMed    


    October 2021
  99. CAFARO G, Perricone C, Riccucci I, Bursi R, et al
    Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjogren's syndrome and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Oct 18. pii: 17870.
    PubMed     Abstract available


    September 2021
  100. KLEMM P, Preusler P, Hudowenz O, Asendorf T, et al
    Effects of multimodal rheumatologic complex treatment in patients with rheumatoid arthritis: a monocentric prospective study.
    Clin Exp Rheumatol. 2021 Sep 28. pii: 17318.
    PubMed     Abstract available


  101. THOMPSON AE, Pope JE
    The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Sep 21. pii: 17449.
    PubMed     Abstract available


  102. RODRIGUEZ-MUGURUZA S, Combe B, Guillemin F, Fautrel B, et al
    Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort.
    Clin Exp Rheumatol. 2021 Sep 21. pii: 17302.
    PubMed     Abstract available


  103. ZHENG B, Soares de Moura C, Machado M, Pineau CA, et al
    Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Sep 7. pii: 17256.
    PubMed     Abstract available


  104. PERNIOLA S, Bizzoca R, Fornaro M, Alivernini S, et al
    High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study.
    Clin Exp Rheumatol. 2021 Sep 7. pii: 16999.
    PubMed     Abstract available


  105. DURAN E, Yildirim BES, Karadag O
    Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.
    Clin Exp Rheumatol. 2021 Sep 7. pii: 17387.
    PubMed    


  106. MARIOTTE A, Bernardi L, Macquin C, DeCauwer A, et al
    NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models.
    Clin Exp Rheumatol. 2021;39:982-987.
    PubMed     Abstract available


  107. YAO H, Wang Y, Wang Z, Zhao J, et al
    The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
    Clin Exp Rheumatol. 2021;39 Suppl 132:129-134.
    PubMed     Abstract available


  108. YANG CA, Chen PK, Lan JL, Chang CK, et al
    Expression signature of inflammation-associated long non-coding RNAs in adult-onset Still's disease.
    Clin Exp Rheumatol. 2021;39 Suppl 132:67-74.
    PubMed     Abstract available


  109. GAO Q, Yuan Y, Wang Y, Jiang J, et al
    Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
    Clin Exp Rheumatol. 2021;39 Suppl 132:59-66.
    PubMed     Abstract available


  110. AIZAKI Y, Yazawa H, Sato K, Mimura T, et al
    Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still's disease.
    Clin Exp Rheumatol. 2021;39 Suppl 132:22-29.
    PubMed     Abstract available


  111. YAMAMOTO S, Nishimura K, Yo K, Waki D, et al
    Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine.
    Clin Exp Rheumatol. 2021;39 Suppl 132:139-140.
    PubMed    


    August 2021
  112. KITAMURA N, Sugiyama K, Nagasawa Y, Hamaguchi M, et al
    Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Aug 5. pii: 17140.
    PubMed     Abstract available


    July 2021
  113. CIESLA M, Kolarz B, Majdan M, Darmochwal-Kolarz D, et al
    Plasma micro-RNA-22 is associated with disease activity in well-established rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 24. pii: 16995.
    PubMed     Abstract available


  114. LEE K, Min HK, Koh SH, Lee SH, et al
    Prognostic signature of interferon-gamma and interleurkin-17A in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 23. pii: 17190.
    PubMed     Abstract available


  115. YOSHIZAWA Y, Nakao T, Tsuritani K, Yamada T, et al
    The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 8. pii: 16877.
    PubMed     Abstract available


  116. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
    Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 17208.
    PubMed     Abstract available


  117. MATSUNO H, Kang YM, Okada M, Lee SI, et al
    Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 16868.
    PubMed     Abstract available


  118. SILVAGNI E, Sakellariou G, Bortoluzzi A, Giollo A, et al
    One year in review 2021: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:705-720.
    PubMed     Abstract available


  119. MONA M, Mondello S, Hyon JY, Saleh W, et al
    Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:795-803.
    PubMed     Abstract available


  120. LORAND V, Nagy G, Balint Z, Komjati D, et al
    Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis.
    Clin Exp Rheumatol. 2021;39 Suppl 131:77-84.
    PubMed     Abstract available


    June 2021
  121. ALVARO GRACIA JM, Barbazan C, Garcia Llorente JF, Munoz-Fernandez S, et al
    Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 26. pii: 17046.
    PubMed     Abstract available


  122. CACCIAPAGLIA F, Renna D, Fornaro M, Venerito V, et al
    Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre.
    Clin Exp Rheumatol. 2021 Jun 25. pii: 16172.
    PubMed    


  123. BOLETO G, Cren JB, Avouac J, Allanore Y, et al
    Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Clin Exp Rheumatol. 2021 Jun 15. pii: 17277.
    PubMed    


  124. PIARULLI A, Conversano C, Ciacchini R, Miniati M, et al
    Catastrophisation, chronic pain and sexuality: a cross-sectional investigation in fibromyalgia and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 10. pii: 17303.
    PubMed     Abstract available


  125. SAITOU M, Noda K, Matsushita T, Ukichi T, et al
    Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory.
    Clin Exp Rheumatol. 2021 Jun 8. pii: 17108.
    PubMed     Abstract available


  126. RAMIREZ J, Azuaga-Pinango AB, Frade-Sosa B, Gumucio-Sanguino R, et al
    Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 8. pii: 16966.
    PubMed     Abstract available


    May 2021
  127. WINTHROP KL, Tanaka Y, Lee EB, Wollenhaupt J, et al
    Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review.
    Clin Exp Rheumatol. 2021 May 28. pii: 16343.
    PubMed     Abstract available


  128. BEHRENS F, Burmester GR, Feuchtenberger M, Kellner H, et al
    Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
    Clin Exp Rheumatol. 2021 May 14. pii: 16554.
    PubMed     Abstract available


  129. THALMANN R, von Kempis J, Zgraggen A, Graf N, et al
    Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high worsening of patient-related outcomes.
    Clin Exp Rheumatol. 2021 May 5. pii: 16889.
    PubMed     Abstract available


  130. TESTA D, Calvacchi S, Petrelli F, Giannini D, et al
    One year in review 2021: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:445-452.
    PubMed     Abstract available


  131. KONDO Y, Kaneko Y, Takei H, Tamai H, et al
    COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
    Clin Exp Rheumatol. 2021;39:631-638.
    PubMed     Abstract available


  132. DITTO MC, Parisi S, Varisco V, Talotta R, et al
    Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
    Clin Exp Rheumatol. 2021;39:546-554.
    PubMed     Abstract available


  133. IANNUCCELLI C, Lucchino B, Gioia C, Dolcini G, et al
    Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39 Suppl 130:153-160.
    PubMed     Abstract available


  134. ALMIRALL M, Martinez-Mateu SH, Alegre C, Collado A, et al
    Dietary habits in patients with fibromyalgia: a cross-sectional study.
    Clin Exp Rheumatol. 2021;39 Suppl 130:170-173.
    PubMed     Abstract available


    April 2021
  135. RETUERTO M, Trujillo E, Valero C, Fernandez-Espartero C, et al
    Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study.
    Clin Exp Rheumatol. 2021 Apr 27. pii: 17091.
    PubMed     Abstract available


  136. AVOUAC J, Degrave R, Vergneault H, Combier A, et al
    Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
    Clin Exp Rheumatol. 2021 Apr 23. pii: 16697.
    PubMed     Abstract available


  137. DI CARLO M, Tardella M, Filippucci E, Carotti M, et al
    Lung ultrasound in patients with rheumatoid arthritis: definition of significant interstitial lung disease.
    Clin Exp Rheumatol. 2021 Apr 23. pii: 16655.
    PubMed     Abstract available


    March 2021
  138. PERTSINIDOU E, Manivel VA, Westerlind H, Klareskog L, et al
    Rheumatoid arthritis autoantibodies and their association with age and sex.
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16843.
    PubMed     Abstract available


  139. HASSELI R, Pfeil A, Hoyer BF, Krause A, et al
    Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16822.
    PubMed     Abstract available


  140. PATLAN M, Paez A, Masso F, Amezcua-Guerra LM, et al
    Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16892.
    PubMed    


  141. ZHAO X, Gan Y, Jin Y, He J, et al
    Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:378-384.
    PubMed     Abstract available


  142. CAMPOCHIARO C, Tomelleri A, Galli E, Cocchiara E, et al
    Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
    Clin Exp Rheumatol. 2021;39 Suppl 129:129-134.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: